학술논문

Competing risk survival analysis in patients with symptomatic waldenström macroglobulinemia: The impact of disease unrelated mortality and of rituximab-based primary therapy
Document Type
Letter
Source
In: Haematologica. (Haematologica, 31 October 2015, 100(11):e448-e449)
Subject
Language
English
ISSN
15928721
03906078